November 18, 2025
Attention deficit hyperactivity disorder (ADHD) is one of the most common behavioral health conditions in children, and managing it well can make a world of difference. When prescribed and monitored appropriately, medication can effectively alleviate symptoms like hyperactivity, impulsiveness, and trouble focusing – and health care providers play a crucial role in this process.
Recognizing the importance of ongoing care for ADHD, the Healthcare Effectiveness Data and Information Set (HEDIS®) includes a dedicated measure: Follow-Up Care for Children Prescribed ADHD Medication (ADD-E).
What is the HEDIS ADD-E measure?
This measure tracks the level of support provided to children aged 6–12 who have been prescribed ADHD medication. There are two key phases:
| Our 2024 HEDIS ADD-E results From January to December 2024, there was little change in Evernorth® Behavioral Health-participating providers’ follow-up care rates for children prescribed ADHD medication. Both the initiation and maintenance rates fell short of the HEDIS goal. We are committed to supporting providers in their efforts to improve follow-up care rates—and help more children thrive. |
Practical tips for providers
Here are some simple, effective ways to help families stay on track:
Why HEDIS matters
HEDIS is a widely used tool for measuring and improving the quality of care. For behavioral health, these measures help ensure patients get the right care at the right time—affordably and effectively.
Additional resources
Want to learn more or share information with your patients? Check out these helpful links:
1 HEDIS is a registered trademark of NCQA.
2 Follow-up care is defined as a subsequent appointment with a qualified health care provider, which helps ensure medication compliance.
Please let us know what you think of the Provider Newsroom information and news.
Contact Us